- Home
- MDXG vs UDMY Comparison
MDXG vs UDMY Comparison
Compare MDXG & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- UDMY
- Stock Information
- Founded
- MDXG 2006
- UDMY 2009
- Country
- MDXG United States
- UDMY United States
- Employees
- MDXG N/A
- UDMY N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- UDMY Other Consumer Services
- Sector
- MDXG Health Care
- UDMY Real Estate
- Exchange
- MDXG Nasdaq
- UDMY Nasdaq
- Market Cap
- MDXG 1.1B
- UDMY 1.3B
- IPO Year
- MDXG N/A
- UDMY 2021
- Fundamental
- Price
- MDXG $9.32
- UDMY $7.44
- Analyst Decision
- MDXG Strong Buy
- UDMY Buy
- Analyst Count
- MDXG 5
- UDMY 9
- Target Price
- MDXG $12.00
- UDMY $11.06
- AVG Volume (30 Days)
- MDXG 1.1M
- UDMY 750.9K
- Earning Date
- MDXG 10-30-2024
- UDMY 10-29-2024
- Dividend Yield
- MDXG N/A
- UDMY N/A
- EPS Growth
- MDXG N/A
- UDMY N/A
- EPS
- MDXG 0.52
- UDMY N/A
- Revenue
- MDXG $342,804,000.00
- UDMY $776,168,000.00
- Revenue This Year
- MDXG $9.56
- UDMY $9.33
- Revenue Next Year
- MDXG $9.19
- UDMY $3.37
- P/E Ratio
- MDXG $17.47
- UDMY N/A
- Revenue Growth
- MDXG 10.93
- UDMY 10.14
- 52 Week Low
- MDXG $5.47
- UDMY $6.67
- 52 Week High
- MDXG $9.49
- UDMY $16.01
- Technical
- Relative Strength Index (RSI)
- MDXG 80.34
- UDMY 36.25
- Support Level
- MDXG $8.55
- UDMY $7.40
- Resistance Level
- MDXG $9.49
- UDMY $9.03
- Average True Range (ATR)
- MDXG 0.41
- UDMY 0.32
- MACD
- MDXG 0.18
- UDMY -0.13
- Stochastic Oscillator
- MDXG 93.10
- UDMY 1.53
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The Company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.